Clinical and Translational Science Institute

Finished

Imaging of Osteonecrosis of the Femoral Head

Alsaker, B.

12/1/21 → 2/1/22

Project: Research project

Moving Human Papillomavirus (HPV) Self-Sampling into Primary Care Clinics: A Pre-Implementation Study to Address Cervical Cancer Screening Inequities in Minnesota

Xiong, S.

9/1/20 → 8/1/21

Project: Internal Grant

An observational retrospective cohort study of systemic therapies for relapsed or refractory diffuse large B cell lymphoma (R/R DLBCL), to compare outcomes to those from Tafasitamab + Lenalidomide in the L-MIND study

Bachanova, V.

MORPHOSYS AG

6/30/20 → 4/28/21

Project: Research project

Multi-center cross-sectional epidemiological study to characterize the prevalence and distribution of lipoprotein(a) levels among patients with established cardiovascular disease

Duprez, D.

NOVARTIS PHARMACEUTICALS CORPORATION

4/1/20 → 8/30/22

Project: Research project

FT516-102:APhase I, Open-Label, Multicenter Study of FT516 in Combination with Monoclonal Antibodies in Subjectswith Advanced Solid Tumors

Patel, M. R.

FATE THERAPEUTICS, INC.

2/20/20 → 3/1/23

Project: Research project

A Phase 2, Multi-Center, Open-Label Study to Evaluate Long-term Safety and Efficacy of CXA-10 in Subjects with Pulmonary Arterial Hypertension on Stable Background Therapy: Extension to Study CXA-10-301 (Complexa CXA-10-2302 - PRIMEx Open Label Extension

Prins, K. W.

COMPLEXA INC

2/1/20 → 2/28/23

Project: Research project

CB8025-21845: A Phase 2, Randomized, Double Blind, Placebo Controlled, Multiple CenterStudy To Evaluate The Safety, Tolerability, And Efficacy Of Seladelpar AdministeredFor 24 Weeks In Adult Subjects With Primary Sclerosing Cholangitis

Lake, J. R.

CYMABAY THERAPEUTICS, INC

1/29/20 → 7/30/20

Project: Research project

A Study to Characterize the Genetic, Biomarker, and Clinical Profile of Patients with Focal Segmental Glomerulosclerosis (FSGS), Treatment-Resistant Minimal Change Disease (TR-MCD), and Diabetic Nephropathy (DN)

Zand, L.

GOLDFINCH BIO

12/12/19 → 9/30/20

Project: Research project

ExtraVascular Implantable Cardioverter Defibrillator(EV ICD) Pivotal Study

Roukoz, H.

MEDTRONIC INC

10/1/19 → 10/31/23

Project: Research project

MT2018-35 A Randomized Phase 2 Study of Obinutuzumab for Prevention of Chronic Graft vs. HostDisease After Allogeneic Peripheral Blood Stem Cell Transplantation

El Jurdi, N.

DANA-FARBER CANCER INSTITUTE

10/1/19 → 9/30/23

Project: Research project

METFORMIN FOR OVERWEIGHT &OBESE CHILDREN AND ADOLESCENTS WITH BIPOLAR SPECTRUMDISORDERS TREATED WITH SECOND-GENERATION ANTIPSYCHOTICS.

Cullen, K. R.

THE FEINSTEIN INST FOR MEDICAL RESEARCH, PATIENT-CENTERED OUTCOMES RESEARCH INST.

9/1/19 → 12/31/22

Project: Research project

A Phase 2 Randomized, Dose-blind, Multicenter Study to Evaluate the Safety and Efficacy of KZR-616 in the Treatment of Patients with Autoimmune Hemolytic Anemia and Immune Thrombocytopenia

Vercellotti, G. M. & Mazepa, M.

KEZAR LIFE SCIENCES, INC

8/20/19 → 9/1/20

Project: Research project

MMP-01: Pilot Study Evaluating Activity of the Combination of Anti-PD-1 Antibody with High Dose IL-2 in Metastatic Melanoma

Domingo-Musibay, E.

HOOSIER CANCER RESEARCH NETWORK, INC

8/12/19 → 12/31/19

Project: Research project

A Long-Term Non-Interventional Registry to Assess Safety and Effectiveness of HUMIRA (Adalimumab) in Patients with Moderately to Severely Active Ulcerative Colitis (UC)

Shmidt, E.

ABBVIE INC

7/18/19 → 6/30/20

Project: Research project

Transfemoral Replacement of Aortic Valve with HLT MeriDIAN Valve CE Mark Trial

Raveendran, G.

HEART LEAFLET TECHNOLOGIES, INC

7/1/19 → 7/31/23

Project: Research project

FT-004: Long-term Follow-Up Study Following Treatment with Fate Therapeutics Cellular Immunotherapy

Brunstein, C. G.

FATE THERAPEUTICS, INC.

6/26/19 → 2/23/21

Project: Research project

MT2018-36 INSPIRE: A Multicenter Randomized Controlled Trial integrating health informatics in a scalablestepped care self-management program for survivors after hematopoietic cell transplantation

Holtan, S. G.

FRED HUTCHINSON CANCER CENTER, NIH NATIONAL CANCER INSTITUTE (NCI)

5/1/19 → 4/30/20

Project: Research project

A Double-Blind, Randomized, Placebo-Controlled Study of Levosimendan in Pulmonary HypertensionPatients with Heart Failure and Preserved Left Ventricular Ejection Fraction (PHHFpEF)

Thenappan, T.

TENAX THERAPEUTICS, INC

4/1/19 → 4/30/23

Project: Research project

iELEVATE (Improving womEn's and chiLdren's hEalth Via biobanking and elecTronic rEgistry)

Eder, M.

THE UNIVERSITY OF IOWA, NATIONAL INSTITUTES OF HEALTH (NIH)

3/13/19 → 2/28/22

Project: Research project

Protocol ATI001-102 Substudy: Evaluation of Ad-RTS-hIL-12 + Veledimex in Combination with Nivolumabin Subjects with Recurrent or Progressive Glioblastoma

Chen, C. C.

ZIOPHARM ONCOLOGY, INC.

2/21/19 → 2/28/23

Project: Research project

SUBA-itraconazole versus conventional itraconazole in the treatment of endemic mycoses; a multi-center,open-label, randomized comparative trial

Young, J. H.

THE UNIVERSITY OF ALABAMA AT BIRMINGHAM, MAYNE PHARMA INTERNATIONAL

2/14/19 → 2/28/23

Project: Research project

Protocol Writing, Review, IRB submission for: A Phase I/II Trial in Patients with Metastatic Gastrointestinal Epithelial Cancer Administering Tumor-Infiltrating Lymphocytes in which the Gene Encoding CISH was Inactivated Using the CRISPR/ Cas9 System

Lou, E.

INTIMA BIOSCIENCES, INC

2/1/19 → 8/1/20

Project: Research project

Phase I/II pharmacokinetic multi-tumor study of subcutaneous formulation of nivolumab monotherapy

Domingo-Musibay, E.

BRISTOL-MYERS SQUIBB COMPANY

2/1/19 → 1/30/20

Project: Research project

A Single-arm, Phase 2 Study to Evaluate the Safety and Efficacy of IMMU-132 in Patients with MetastaticCastration-Resistant Prostate Cancer Who Have Progressed on Second Generation AR-Directed Therapy

Rao, A.

PROSTATE CANCER CLINTRIAL CONSORTIUM LLC, IMMUNOMEDICS, INC

12/1/18 → 6/30/19

Project: Research project

STEMI COOL Trial: A multicenter, prospective, randomized-controlled trial to assess cooling as anadjunctive therapy to percutaneous interventional in patients with acute myocardial infarction

Yannopoulos, D.

ZOLL MEDICAL CORPORATION

12/1/18 → 12/31/22

Project: Research project

A Phase 3 Study of Itacitinib or Placebo in Combination With Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease

El Jurdi, N.

INCYTE CORPORATION

11/27/18 → 11/30/23

Project: Research project

Comparison of operative to monitoring and endocrine therapy (COMET) trial for low risk DCIS: A phase IIIprospective randomized trial

Blaes, A. H.

ALLIANCE FOUNDATION TRIALS, LLC, PATIENT-CENTERED OUTCOMES RESEARCH INST.

11/8/18 → 11/30/23

Project: Research project

A Phase 3, Randomized, Study of Neoadjuvant Chemotherapy alone versus Neoadjuvant Chemotherapyplus Nivolumab or Nivolumab and BMS-986205, Followed by Continued Post-Surgery Therapy withNivolumab or Nivolumab and BMS-986205 in Participants with

Rao, A. & Gupta, S.

BRISTOL-MYERS SQUIBB COMPANY

11/1/18 → 11/30/23

Project: Research project

A Phase 3, Randomized, Double-Arm, Open-Label, Controlled Trial of ASP-1929 PhotoimmunotherapyVersus Physician???s Choice Standard of Care for the Treatment of Locoregional, Recurrent Head andNeck Squamous Cell Carcinoma in Patients Who Have Failed or

Khariwala, S. S. & Yueh, B.

RAKUTEN ASPYRIAN, INC.

11/1/18 → 10/30/22

Project: Research project

HM2018-32 A Phase 1b Open-Label Study to Evaluate the Safety and Antitumor Activity of LoncastuximabTesirine and Ibrutinib in Patients with Advanced Diffuse Large B-Cell Lymphoma or Mantle Cell Lymphoma

Maakaron, J., Janakiram, M. & Pongas, G.

ADC THERAPEUTICS SA

11/1/18 → 4/30/23

Project: Research project

A Phase II trial of bevacizumab and rucaparib in recurrent carcinoma of the cervix or endometrium

Erickson, B. K.

UNIV. OF OKLAHOMA HEALTH SCIENCES CENTER

10/31/18 → 10/31/23

Project: Research project

FT500-101: FT500 as Monotherapy and in Combination with Immune Checkpoint Inhibitors in Subjects with AdvancedSolid Tumors

Patel, M. R.

FATE THERAPEUTICS, INC.

10/1/18 → 3/1/23

Project: Research project

Prospective Randomized Trial of the Optimal Evaluation of Cardiac Symptoms and Revascularization

Nijjar, P. S.

HEARTFLOW, INC

10/1/18 → 10/30/22

Project: Research project

A Randomized, Phase 3 Study of Eryaspase in Combination with Chemotherapy versus Chemotherapy Alone as Second-Line Treatment in Patients with Pancreatic AdenocarcinomaTRYbeCA-1 - Trial of Eryaspase in pancreatic Cancer

Greeno, E. W.

ERYTECH PHARMA, INC

10/1/18 → 10/30/22

Project: Research project

Direct Oral Anticoagulants (DOACs) versus LMWH +/- Warfarin for VTE in Cancer: A Randomized Effectiveness Trial (CANVAS Trial)

Shah, S.

ALLIANCE FOUNDATION TRIALS, LLC, PATIENT-CENTERED OUTCOMES RESEARCH INST.

9/24/18 → 1/17/22

Project: Research project

Phase I/II Study of Ixazomib and Romidepsin in Relapsed/Refractory Peripheral T-cell Lymphoma (PTCL): Big Ten Cancer Research Consortium BTCRC-HEM15-028

Janakiram, M.

BIG TEN CANCER RESEARCH CONSORTIUM, TAKEDA DEVELOPMENT CENTER AMERICAS, INC.

9/1/18 → 8/30/22

Project: Research project

PREcision Event Monitoring of PatienTs with Heart Failure using HeartLogicTM

Alexy, T.

BOSTON SCIENTIFIC CORPORATION

9/1/18 → 9/30/22

Project: Research project

A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Effectsof SOtagLiflozin on Clinical Outcomes in HemOdynamIcally STable Patients with Type 2 Diabetes POSTWorsening Heart Failure

Alexy, T.

SANOFI-AVENTIS US

9/1/18 → 9/30/22

Project: Research project

Cognitive Effects of Androgen Receptor (AR) Directed Therapies for Advanced Prostate Cancer.

Antonarakis, E.

NORTHWESTERN UNIVERSITY, PROSTATE CANCER FOUNDATION

8/31/18 → 8/22/23

Project: Research project

A multi-centre, double-blind, placebo-controlled, randomised phase II trial to compare efficacy of xentuzumab in combination with everolimus and exemestane versus everolimus and exemestane in post-menopausal women with HR+ / HER2- metastatic breast can

Beckwith, H. C.

BOEHRINGER-INGELHEIM PHARMACEUTICALS

8/30/18 → 8/30/23

Project: Research project

REmodeling the Left Ventricle with Atrial Modulated Pacing (REVAMP)

Can, I.

MEDTRONIC INC

8/1/18 → 8/31/22

Project: Research project

An Open Label Study of SC-005 in Subjects with Triple Negative Breast Cancer (TNBC)

Yee, D.

ABBVIE INC

8/1/18 → 2/28/19

Project: Research project

A Phase 2, Randomized, Open-label Study of Nivolumab or Nivolumab/BMS-986205 Alone or Combinedwith Intravesical BCG in Participants with BCG-Unresponsive, High-Risk,Non-Muscle Invasive BladderCancer

Zabell, J. R. & Konety, B. R.

BRISTOL-MYERS SQUIBB COMPANY

7/5/18 → 7/30/23

Project: Research project

A prospective, multi-center, Phase 1b/2a study to assess the safety and tolerability of different doses ofAG019 administered alone or in association with teplizumab in subjects with clinical recent-onset Type 1Diabetes Mellitus (T1D).

Moran, A.

INTREXON CORPORATION

7/1/18 → 7/31/22

Project: Research project

A Phase II, Multi-center, Open-label Study of a Conditionally Replicative Adenovirus (DNX-2401) with Pembrolizumab (KEYTRUDA) for Recurrent Glioblastoma or Gliosarcoma

Chen, C. C.

DNATRIX, INC

5/31/18 → 5/31/23

Project: Research project

A Phase 1b/2a, Multi-Center Open-Label Study to Evaluate the Safety and Efficacy of CombinationTreatment with MEDI0457 (INO-3112) and Durvalumab (MEDI4736) in Patients with Recurrent / MetastaticHuman Papilloma Virus Associated Head and Neck Squamous

Fujioka, N.

ASTRAZENECA

5/16/18 → 5/30/23

Project: Research project

A Randomized, Double-Blind, Placebo-Controlled Pilot Stu

Peterson, B. A.

ALLIANCE FOR CLINICAL TRIALS IN ONCOLOGY, NATIONAL INSTITUTES OF HEALTH (NIH)

5/1/18 → 4/30/22

Project: Research project

A PHASE 1/2, OPEN-LABEL, MULTICENTER, DOSE ESCALATION AND DOSE EXPANSION STUDY OFNKTR-262 IN COMBINATION WITH NKTR-214 AND IN COMBINATION WITH NKTR-214 PLUS NIVOLUMABIN PATIENTS WITH LOCALLY ADVANCED OR METASTATIC SOLID TUMOR MALIGNANCIES

Domingo-Musibay, E.

NEKTAR THERAPEUTICS

5/1/18 → 5/31/22

Project: Research project

Furoscix Real-World Evaluation for Decreasing Hospital Admissions in Heart Failure: FREEDOM-HF TrialProtocol

Alexy, T.

SCPHARMACEUTICALS INC.

5/1/18 → 7/31/20

Project: Research project

A Phase Ib Trial of Neoadjuvant MEDI 4736 +/- Tremelimumab in Locally Advanced Renal Cell Carcinoma

Zabell, J. R.

CLEVELAND CLINIC, ASTRAZENECA

5/1/18 → 5/31/22

Project: Research project

Clinical and Translational Science Institute

Projects

Search results